Home > NRC Library > ADAMS Public Documents
Final response to FOIA request for documents.Forwards documents listed in App A being made available in PDR.App B records being withheld in part (ref FOIA Exemption 6).
Accession Number: ML20199E768
Date Released: Monday, October 28, 2024
Package Contents
The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
- ML20199E762 - Final response to FOIA request for documents.Forwards documents listed in App A being made available in PDR.App B records being withheld in part (ref FOIA Exemption 6). (6 page(s), 11/17/1997)
- ML20199F679 - Forwards partially deleted ltr answering question re usage of isotopes under license 20-03814-73. (2 page(s), 10/9/1962)
- ML20199G516 - Confirms addl info discussed qualitatively on 620109 in telcon re radiographs of individuals for non-diagnostic purposes using Yb-169 radiation sources. (4 page(s), 1/26/1962)
- ML20199G611 - Forwards copies of work,to date for approval for consideration of study for license 20-03717-37. (42 page(s), 5/9/1961)
- ML20199E915 - Forwards BA Little work,to date re license 20-03717-37 H63 application for continuation of project & permission to study further forty patients. (5 page(s), 1/12/1962)
- ML20199E907 - Forwards rept of experience in use of Se-75 in pancreas scanning & results on use of tritium labeled estradiol to detect metabolites in blood of patients w/mammary,ovarian & prostatic carcinoma & protocals. (35 page(s), 10/11/1966)
- ML20199G323 - Informs that application to use C14 labeled chemotherapeutic agent inadvertently labeled 20-551-41 instead of 20-551-40. Photocopy of application to use I-125 human gamma globulin & I-125 human serum albumin encl. (46 page(s), 12/4/1967)
- ML20199E783 - FOIA request for documents re any & all agency records within NRC possession,custody or control concerning human radiation experiments,which identify individuals upon whom radiation experiments were conducted. (8 page(s), 7/16/1997)
- ML20199G480 - Application for license,authorizing 50 microcuries for human use.Ten microcuries of carbon 14 labelled tryptophan will be administered orally to patient w/known metastatic malignant carcinoid diseases. (4 page(s), 5/15/1959)
- ML20199E900 - Requests extension of 200 addl case studies utilizing SnPP04 from New England Nuclear to present license.Case summary rept forms encl. (6 page(s), 3/14/1973)
- ML20199G633 - Discusses ltr in response to recent site visit insp of Univ of Oklahoma.Explanation to two items of noncompliance found in insp submitted. (81 page(s), 3/18/1974)
- ML20199G406 - Recommends Epstein application for AEC license w/o reservation. (3 page(s), 5/26/1967)
- ML20199E890 - Submits purpose,results & toxicity of study re reply to DML:IB:JPV (97114). (5 page(s), 12/12/1967)
- ML20199G576 - Application for license,authorizing 5mc acetic anhydride & 5mc thiosemicarbazide compounds will be used in formation of labelled derivatives of steroid hormones for their quantitative estimation. (2 page(s), 12/4/1961)
- ML20199G260 - Submits yearly rept of use of Tc-99m polyphosphate as bone scanning agent as authorized by amend 39 & 40 of license 37-00062-03. (4 page(s), 4/12/1974)
